Allogeneic hematopoietic stem cell transplantation for nonmalignant hematologic disorders using chemotherapy-only cytoreductive regimens and T-cell-depleted grafts from human leukocyte antigen–matched or –mismatched donors

References

• Tolar J, Mehta PA, Walters MC. Hematopoietic cell transplantation for nonmalignant disorders. Biol Blood Marrow Transplant. 2012;18(1 Suppl):S166–S171. doi: 10.1016/j.bbmt.2011.10.023.
   Google Scholar
• Deeg HJ, Amylon ID, Harris RE, et al. Marrow transplants from unrelated donors for patients with aplastic anemia: minimum effective dose of total body irradiation. Biol Blood Marrow Transplant. 2001;7:208–115.
   PubMed Web of Science ®Google Scholar
• Hill GR, Crawford JM, Cooke KR, Brinson YS, Pan L, Ferrara JL. Total body irradiation and acute graft-versus-host disease: the role of gastrointestinal damage and inflammatory cytokines. Blood. 1997;90:3204–3213.
   PubMed Web of Science ®Google Scholar
• Corvo R, Paoli G, Barra S, et al. Total body irradiation correlates with chronic graft versus host disease and affects prognosis of patients with acute lymphoblastic leukemia receiving an HLA identical allogeneic bone marrow transplant. Int J Radiat Oncol Biol Phys. 1999;43:497–503.
   PubMed Web of Science ®Google Scholar
• Sanders JE. The impact of marrow transplant preparative regimens on subsequent growth and development. The Seattle Marrow Transplant Team. Semin Hematol. 1991;28:244–249.
   PubMed Web of Science ®Google Scholar
• Khoshniat M, Ghavamzadeh A, Larijani B, Bahar B, Tabatabaei O. Effect on growth parameters of bone marrow transplantation with a chemotherapy-only conditioning regimen. Transplant Proc. 2003;35:3085–3088.
   PubMed Web of Science ®Google Scholar
• Kernan NA, Flomenberg N, Collins NH, O'Reilly RJ, Dupont B. Quantitation of T lymphocytes in human bone marrow by a limiting dilution assay. Transplantation. 1985;40:317–322.
   PubMed Web of Science ®Google Scholar
• Collins NH, Carabasi MH, Bleau S, et al. New technology for the depletion of T cells from soybean lectin agglutinated, HLA-matched bone marrow grafts for leukemia: initial laboratory and clinical results. Prog Clin Biol Res. 1992;377:427–439.
   PubMedGoogle Scholar
• Peters C, Matthes-Martin S, Fritsch G, et al. Transplantation of highly purified peripheral blood CD34+ cells from HLA-mismatched parental donors in 14 children: evaluation of early monitoring of engraftment. Leukemia. 1999;13:2070–2078.
   PubMed Web of Science ®Google Scholar
• Small TN, Papadopoulos EB, Boulad F, et al. Comparison of immune reconstitution after unrelated and related T-cell-depleted bone marrow transplantation: effect of patient age and donor leukocyte infusions. Blood. 1999;93:467–480.
   PubMed Web of Science ®Google Scholar
• Chaudhury S, Auerbach AD, Kernan NA, et al. Fludarabine-based cytoreductive regimen and T-cell-depleted grafts from alternative donors for the treatment of high-risk patients with Fanconi anaemia. Br J Haematol. 2008;140:644–655. doi: 10.1111/j.1365-2141.2007.06975.x.
   PubMed Web of Science ®Google Scholar
• Filipovich AH, Weisdorf D, Pavletic S, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant. 2005;11:945–956. doi: 10.1016/j.bbmt.2005.09.004.
   PubMed Web of Science ®Google Scholar
• Peinemann F, Grouven U, Kroger N, Pittler M, Zschorlich B, Lange S. Unrelated donor stem cell transplantation in acquired severe aplastic anemia: a systematic review. Haematologica. 2009;94:1732–1742. doi: 10.3324/haematol.2009.007583.
   PubMed Web of Science ®Google Scholar
• Gadalla SM, Sales-Bonfim C, Carreras J, et al. Outcomes of allogeneic hematopoietic cell transplantation in patients with dyskeratosis congenita. Biol Blood Marrow Transplant. 2013;19:1238–1243. doi: 10.1016/j.bbmt.2013.05.021.
   PubMed Web of Science ®Google Scholar
• King S, Germeshausen M, Strauss G, Welte K, Ballmaier M. Congenital amegakaryocytic thrombocytopenia: a retrospective clinical analysis of 20 patients. Br J Haematol. 2005;131:636–644. doi: 10.1111/j.1365-2141.2005.05819.x.
   PubMed Web of Science ®Google Scholar
• Lackner A, Basu O, Bierings M, et al. Haematopoietic stem cell transplantation for amegakaryocytic thrombocytopenia. Br J Haematol. 2000;109:773–775.
   PubMed Web of Science ®Google Scholar
• Tarek N, Kernan NA, Prockop SE, et al. T-cell-depleted hematopoietic SCT from unrelated donors for the treatment of congenital amegakaryocytic thrombocytopenia. Bone Marrow Transplant. 2012;47:744–746. doi: 10.1038/bmt.2011.142.
   PubMed Web of Science ®Google Scholar
• Zeidler C, Welte K, Barak Y, et al. Stem cell transplantation in patients with severe congenital neutropenia without evidence of leukemic transformation. Blood. 2000;95:1195–1198.
   PubMed Web of Science ®Google Scholar
• Schuetz C, Hoenig M, Gatz S, et al. Hematopoietic stem cell transplantation from matched unrelated donors in chronic granulomatous disease. Immunol Res. 2009;44:35–41. doi: 10.1007/s12026-008-8068-3.
   PubMed Web of Science ®Google Scholar
• Kobos R, Steinherz PG, Kernan NA, et al. Allogeneic hematopoietic stem cell transplantation for pediatric patients with treatment-related myelodysplastic syndrome or acute myelogenous leukemia. Biol Blood Marrow Transplant. 2012;18:473–480. doi: 10.1016/j.bbmt.2011.11.009.
   PubMed Web of Science ®Google Scholar
• Lacerda JF, Martins C, Carmo JA, et al. Haploidentical stem cell transplantation with purified CD34 cells after a chemotherapy-alone conditioning regimen. Biol Blood Marrow Transplant. 2003;9:633–642. doi: 10.1016/S1083.
   PubMed Web of Science ®Google Scholar
• Bayraktar UD, de Lima M, Saliba RM, et al. Ex vivo T cell-depleted versus unmodified allografts in patients with acute myeloid leukemia in first complete remission. Biol Blood Marrow Transplant. 2013;19:898–903. doi: 10.1016/j.bbmt.2013.02.018.
   PubMed Web of Science ®Google Scholar
• Mattsson J, Ringden O, Storb R. Graft failure after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2008;14(Suppl 1):165–170. doi: 10.1016/j.bbmt.2007.10.025.
   PubMed Web of Science ®Google Scholar
• Jakubowski AA, Small TN, Kernan NA, et al. T cell-depleted unrelated donor stem cell transplantation provides favorable disease-free survival for adults with hematologic malignancies. Biol Blood Marrow Transplant. 2011;17:1335–1342. doi: 10.1016/j.bbmt.2011.01.005.
   PubMed Web of Science ®Google Scholar
• Sabloff M, Chandy M, Wang Z, et al. HLA-matched sibling bone marrow transplantation for beta-thalassemia major. Blood. 2011;117:1745–1750. doi: 10.1182/blood-2010-09-306829.
   PubMed Web of Science ®Google Scholar
• Fioredda F, Iacobelli S, van Biezen A, et al. Stem cell transplantation in severe congenital neutropenia: An analysis from the European Society for Blood and Marrow Transplantation. Blood. 2015 Oct 15;126(16):1885–1892. Outcomes of haematopoietic stem cell transplantation (HSCT) for severe congenital neutropenia preliminary results [PH0083]. Presented at EBMT; March 30 to April 2, 2014; Milan.
   Google Scholar